Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| ß-glucan {Beta-Glucan} - Anaerobutyricum |
👶
High Molecular Weight Barley Γ-Glucan Alters Gut Microbiota Toward Reduced Cardiovascular Disease Risk. Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 129 Pub: 2016 Epub: 2016 Feb 10 Authors Wang Y , Ames NP , Tun HM , Tosh SM , Jones PJ , Khafipour E , Html Article Publication |
| ß-glucan {Beta-Glucan} - Anaerobutyricum |
👶
Oat Beta-Glucans Modulate the Gut Microbiome, Barrier Function, and Immune Responses in an In Vivo Model of Early-Stage Colorectal Cancer. International journal of molecular sciences (Int J Mol Sci ) Vol: 25 Issue 24 Pages: Pub: 2024 Dec 19 Epub: 2024 Dec 19 Authors Guzowska M , Dziendzikowska K , Kopiasz L , Gajewska M , Wilczak J , Harasym J , Czerwinska M , Gromadzka-Ostrowska J , Html Article Publication |
| ß-glucan {Beta-Glucan} - Anaerobutyricum |
👶
Dietary Polycan, a Γ-glucan originating from Aureobasidium pullulansSM-2001, attenuates high-fat-diet-induced intestinal barrier damage in obese mice by modulating gut microbiota dysbiosis. Food science & nutrition (Food Sci Nutr ) Vol: 12 Issue 8 Pages: 5824-5835 Pub: 2024 Aug Epub: 2024 May 26 Authors Ko GP , Unno T , Kim YS , Kim J , Html Article Publication |
| ß-glucan {Beta-Glucan} - Anaerobutyricum |
👶
Γ-Glucan alleviates mice with ulcerative colitis through interactions between gut microbes and amino acids metabolism. Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 103 Issue 8 Pages: 4006-4016 Pub: 2023 Jun Epub: 2022 Dec 7 Authors Liu C , Sun C , Cheng Y , Publication |
| ß-glucan {Beta-Glucan} - Anaerobutyricum |
👶
Circadian disruption-induced metabolic syndrome in mice is ameliorated by oat Γ-glucan mediated by gut microbiota. Carbohydrate polymers (Carbohydr Polym ) Vol: 267 Issue Pages: 118216 Pub: 2021 Sep 1 Epub: 2021 May 17 Authors Cheng WY , Lam KL , Li X , Kong AP , Cheung PC , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
